Clinical Trials Logo

Filter by:
  • None
  • Page 1
NCT ID: NCT03164187 Completed - Type2 Diabetes Clinical Trials

Evaluation of Type 2 Diabetes Treatment

Start date: September 1, 2016
Phase: Phase 4
Study type: Interventional

The aim of this study is to analyze the efficacy of Diabeton 60 MR as intensive sugar-lowering therapy into routine clinical practice, in patients for whom the treating physician has already decided to prescribe this medication. This concerns untreated newly diagnosed patients uncontrolled by diet, and patients uncontrolled by metformin.

NCT ID: NCT02957266 Recruiting - Cervical Cancer Clinical Trials

Cervical Cancer Radiotherapy by Use of VMAT, Individualized Polyradiosensitization and Interstitial Brachytherapy

CERVIPIB
Start date: March 2015
Phase: Phase 3
Study type: Interventional

The purpose of this study is to define an effectiveness of concurrent chemoradiotherapy of cervical cancer patients treated by VMAT (volumetric arc therapy) based external beam radiotherapy, polyradiosensitization by cisplatin and gemcitabine and interstitial brachytherapy.

NCT ID: NCT02314754 Completed - Medical Abortion Clinical Trials

Outpatient Medical Abortion With Mifepristone and Misoprostol Through 77 Days of Gestation

XXGA
Start date: December 2014
Phase: Phase 4
Study type: Interventional

To demonstrate non-inferiority of the efficacy of 200 mg mifepristone followed in 24 to 48 hours by 800 µg buccal misoprostol in outpatient medical abortion services among women 71-77 days' compared to women 64-70 days' LMP.

NCT ID: NCT02219100 Completed - Clinical trials for Abortion, First Trimester

Acceptability and Feasibility of a Demedicalized Medical Abortion Regimen in the Caucasus

Start date: November 2010
Phase: N/A
Study type: Interventional

This study examined the acceptability and feasibility of using a simplified regimen of medical abortion in Armenia and Azerbaijan. It was hypothesized that home use of mifepristone and misoprostol, and buccal administration of misoprostol, would be both acceptable to women and efficacious.

NCT ID: NCT02121171 Active, not recruiting - Congenital Glaucoma Clinical Trials

Combined Trab+Trab Versus Combined Trab+Trab With Subconjunctival Implantation of Ologen for Primary Congenital Glaucoma

Start date: September 2010
Phase: Phase 1
Study type: Interventional

The objective of this prospective randomised study is to compare the efficacy and safety of ologen CM (Collagen matrix) as adjunct to combined trabeculotomy-trabecuectomy in congenital glaucoma cases, the efficacy being the primary objective and the safety being the secondary. The investigators hypothesize that combined trabeculotomy-trabecuectomy with Ologen collagen matrix implant implantation in congenital glaucoma is a safer procedure and may yield better results than combined trabeculotomy-trabeculectomy approach.

NCT ID: NCT01912638 Completed - Clinical trials for Steroid Induced Glaucoma

Trabeculectomy With Ologen Collagen Implant vs Trabeculectomy With Provisc in Steroid Induced Glaucoma

Start date: July 2012
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this prospective randomized study is to assess and compare the clinical efficacy and safety of primary trabeculectomy with Ologen® collagen implant and cohesive viscoelastic (Provisc®) - augmented trabeculectomy in patients with medically uncontrolled steroid induced glaucoma.

NCT ID: NCT01800006 Completed - Atrial Fibrillation Clinical Trials

Xarelto for Prevention of Stroke in Patients With Atrial Fibrillation in Latinamerica and EMEA Region

XANTUS-EL
Start date: January 14, 2013
Phase: N/A
Study type: Observational

This international study is a prospective noninterventional observational cohort study of patients with non-valvular atrial fibrillation who are prescribed rivaroxaban under routine treatment conditions to prevent stroke or non-central nervous system systemic embolism. Patients will be followed up for 1 year or until 30 days after end of rivaroxaban therapy in case of therapy was discontinued earlier than 12 months. Serious adverse events will be followed up adequately. Laboratory values (e.g., Hb, HCT, haemoccult) should be documented for each point in time they were measured.

NCT ID: NCT00947375 Terminated - Schizophrenia Clinical Trials

Lamictal TM, Haloperidol Decanoate in Schizophrenia

CMCOBaku
Start date: January 2005
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine the effect of lamotrigine augmentation of Haloperidol decanoate in the treatment of Resistant Schizophrenia predominantly by verbal resistant hallucinosis: A randomized, double-blind, placebo-controlled, study. Nadir A.Aliyev & Zafar N.Aliyev Central Mental Clinic for Outpatients of Baku city of Azerbaijan Republic Abstract: OBJECTIVE: The current paper reports on a double-blind, randomized study of the role of lamotrigine as an augmentation agent to haloperidol decanoate in the treatment of out patient's schizophrenia with verbal resistant hallucinosis.

NCT ID: NCT00386282 Completed - Clinical trials for Abortion, First Trimester

Acceptability and Feasibility of Medical Abortion Using Mifepristone and Buccal Misoprostol

Start date: September 2006
Phase: N/A
Study type: Interventional

This study examined the acceptability and feasibility of introducing a mifepristone-misoprostol regimen of medical abortion into abortion services in two private clinics in Puerto Rico; 2 clinics in Baku, Azerbaijan; 3 clinics in Yerevan, Armenia; and 4 clinics in Mexico City. It was hypothesized that the study regimen would be both acceptable and efficacious.